Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-19-001503
Filing Date
2019-05-15
Accepted
2019-05-15 13:15:35
Documents
45
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q zk1923053.htm 10-Q 470123
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 13983
3 EXHIBIT 32.2 exhibit_32-1.htm EX-32.1 7534
  Complete submission text file 0001178913-19-001503.txt   2219013

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT atms-20190331.xml EX-101.INS 405678
5 XBRL TAXONOMY EXTENSION SCHEMA atms-20190331.xsd EX-101.SCH 28327
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atms-20190331_cal.xml EX-101.CAL 26339
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atms-20190331_def.xml EX-101.DEF 88275
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE atms-20190331_lab.xml EX-101.LAB 167803
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atms-20190331_pre.xml EX-101.PRE 136729
Mailing Address 18 EAST 16TH STREET NEW YORK NY 10003
Business Address 18 EAST 16TH STREET NEW YORK NY 10003 646-233-1454
Artemis Therapeutics, Inc. (Filer) CIK: 0001062128 (see all company filings)

EIN.: 841417774 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24431 | Film No.: 19826766
SIC: 2890 Miscellaneous Chemical Products